Rotavirus vaccines: successes and challenges.

PubWeight™: 1.74‹?› | Rank: Top 3%

🔗 View Article (PMID 24156947)

Published in J Infect on October 22, 2013

Authors

Roger I Glass1, Umesh Parashar, Manish Patel, Jon Gentsch, Baoming Jiang

Author Affiliations

1: Fogarty International Center, National Institutes of Health, 31 Center Drive, Mailstop 2220, Bethesda, MD 20892, USA. Electronic address: glassr@mail.nih.gov.

Articles citing this

Exploring the role of environmental enteropathy in malnutrition, infant development and oral vaccine response. Philos Trans R Soc Lond B Biol Sci (2015) 1.02

The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci (2014) 0.93

Reduction in rotavirus disease due to the infant immunisation programme in England; evidence from national surveillance. J Infect (2015) 0.93

Generation of an Avian-Mammalian Rotavirus Reassortant by Using a Helper Virus-Dependent Reverse Genetics System. J Virol (2015) 0.79

Identification of a Peptide Produced by Bifidobacterium longum CECT 7210 with Antirotaviral Activity. Front Microbiol (2016) 0.78

Immunogenicity of infectious pathogens and vaccine antigens. BMC Immunol (2015) 0.77

Is rotavirus still a major cause for diarrheal illness in hospitalized pediatric patients after rotavirus vaccine introduction in the Saudi national immunization program? Medicine (Baltimore) (2017) 0.75

Epidemiology of Rotavirus-Norovirus Co-Infection and Determination of Norovirus Genogrouping among Children with Acute Gastroenteritis in Tehran, Iran. Iran Biomed J (2016) 0.75

Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs. Gut Pathog (2016) 0.75

Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8]. Virol J (2017) 0.75

Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa. PLoS One (2014) 0.75

Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children. PLoS Negl Trop Dis (2016) 0.75

Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review. Open Forum Infect Dis (2017) 0.75

Articles by these authors

Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97

Recent resurgence of mumps in the United States. N Engl J Med (2008) 2.90

Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis (2005) 2.82

Ricin poisoning: a comprehensive review. JAMA (2005) 2.62

The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet (2004) 2.43

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med (2010) 2.26

Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA (2009) 2.16

Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12

Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr (2008) 2.00

Fine needle aspiration of a neck lump: a mercurial mystery. Br J Oral Maxillofac Surg (2009) 1.93

Workgroup report: public health strategies for reducing aflatoxin exposure in developing countries. Environ Health Perspect (2006) 1.89

Rotavirus antigenemia in patients with acute gastroenteritis. J Infect Dis (2005) 1.89

A high utility integrated map of the pig genome. Genome Biol (2007) 1.88

Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med (2011) 1.83

Early detection of illness associated with poisonings of public health significance. Ann Emerg Med (2005) 1.80

Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis (2005) 1.74

Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol (2005) 1.65

Robotic-assisted nephroureterectomy and bladder cuff excision without intraoperative repositioning. Urology (2011) 1.64

Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics (2008) 1.63

Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol (2009) 1.60

Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis (2007) 1.51

Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J (2010) 1.48

Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr (2013) 1.48

Descriptive epidemiology of fatal respiratory outbreaks and detection of a human-related metapneumovirus in wild chimpanzees (Pan troglodytes) at Mahale Mountains National Park, Western Tanzania. Am J Primatol (2008) 1.42

Disassembly of a rotablator: getting out of a trap. Catheter Cardiovasc Interv (2003) 1.42

Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities. Infect Control Hosp Epidemiol (2004) 1.42

Enhancement of detection and quantification of rotavirus in stool using a modified real-time RT-PCR assay. J Med Virol (2008) 1.41

The efficacy, safety and tolerability of intracavernous PNU-83757 for the treatment of erectile dysfunction. J Urol (2002) 1.39

Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ (2010) 1.39

Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin (2010) 1.39

Global impact of rotavirus vaccines. Expert Rev Vaccines (2010) 1.34

Detection of viral agents in fecal specimens of monkeys with diarrhea. J Med Primatol (2007) 1.29

Prestin-based outer hair cell electromotility in knockin mice does not appear to adjust the operating point of a cilia-based amplifier. Proc Natl Acad Sci U S A (2007) 1.20

Hospital-Based Surveillance of Rotavirus Diarrhea in the People's Republic of China, August 2003-July 2007. J Infect Dis (2009) 1.19

Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol (2012) 1.18

Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J (2013) 1.17

Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus. Am J Epidemiol (2013) 1.17

Sentinel hospital surveillance for rotavirus in latin american and Caribbean countries. J Infect Dis (2009) 1.16

Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010. JAMA (2012) 1.16

Oncogenic action of phospholipase A2 in prostate cancer. Cancer Lett (2005) 1.14

Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine (2010) 1.14

Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. J Infect Dis (2009) 1.14

Childhood intussusception: a literature review. PLoS One (2013) 1.13

Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol (2004) 1.13

A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis (2013) 1.12

The epidemiology and burden of rotavirus in China: a review of the literature from 1983 to 2005. Vaccine (2006) 1.11

Molecular epidemiological profile of rotavirus in South Korea, July 2002 through June 2003: emergence of G4P[6] and G9P[8] strains. J Infect Dis (2005) 1.11

The pathology of rotavirus-associated deaths, using new molecular diagnostics. Clin Infect Dis (2003) 1.10

Adsorption of As(V) and As(III) by nanocrystalline titanium dioxide. Water Res (2005) 1.09

Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding. J Biol Chem (2010) 1.08

Diagnostic accuracy of hospitalist-performed hand-carried ultrasound echocardiography after a brief training program. J Hosp Med (2009) 1.07

The Toxic Exposure Surveillance System (TESS): risk assessment and real-time toxicovigilance across United States poison centers. Toxicol Appl Pharmacol (2005) 1.07

Prolonged Venovenous Extracorporeal Membrane Oxygenation in a Patient With Acute Respiratory Distress Syndrome. ASAIO J (2016) 1.07

Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis (2008) 1.07

G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J Infect Dis (2009) 1.07

Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis (2005) 1.06

Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine (2006) 1.05

Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem (2007) 1.05

Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA (2012) 1.05

Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J Virol (2007) 1.05

Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One (2012) 1.05

Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience. J Urol (2007) 1.04

Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J (2004) 1.04

Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3. J Infect (2005) 1.02

Epidemiological profile of rotavirus infection in the Republic of Korea: results from prospective surveillance in the Jeongeub District, 1 July 2002 through 30 June 2004. J Infect Dis (2005) 1.02

Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001. Emerg Infect Dis (2003) 1.02

TGF-beta 1 inhibits mast cell Fc epsilon RI expression. J Immunol (2005) 1.00

Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine (2012) 1.00

Identification of enteroviruses in naturally infected captive primates. J Clin Microbiol (2008) 0.99

Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med (2006) 0.99

Removal of arsenic from groundwater by granular titanium dioxide adsorbent. Chemosphere (2005) 0.99

Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ (2013) 0.97

Norovirus detection and genotyping for children with gastroenteritis, Brazil. Emerg Infect Dis (2007) 0.97

Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. J Antimicrob Chemother (2004) 0.97

Importance and challenges of accurately counting rotavirus deaths in China, 2002. Vaccine (2009) 0.96

Quantitative evaluation of rotaviral antigenemia in children with acute rotaviral diarrhea. J Infect Dis (2006) 0.96

The complete genome sequences for three simian enteroviruses isolated from captive primates. Arch Virol (2008) 0.96

Rotavirus and rotavirus vaccines. Adv Exp Med Biol (2006) 0.95

Serum IgG mediates mucosal immunity against rotavirus infection. Proc Natl Acad Sci U S A (2005) 0.95

Rotavirus disease burden among children <5 years of age--Santa Rosa, Guatemala, 2007-2009. Trop Med Int Health (2011) 0.95

Molecular characterization of human rotavirus vaccine strain CDC-9 during sequential passages in Vero cells. Hum Vaccin (2010) 0.94

Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics (2012) 0.93

Hypothermia and other cold-related morbidity emergency department visits: United States, 1995-2004. Wilderness Environ Med (2008) 0.93

Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine. Vaccine (2009) 0.93

Diverse origin of P[19] rotaviruses in children with acute diarrhea in Taiwan: Detection of novel lineages of the G3, G5, and G9 VP7 genes. J Med Virol (2011) 0.93

Epidemiologic and clinical features of other enteric viruses associated with acute gastroenteritis in American Indian infants. J Pediatr (2012) 0.93